Atlas Trials

PD-1 Knockout Engineered T Cells for Metastatic Renal Cell Carcinoma.

Clinical trial NCT02867332 · WITHDRAWN

Trial details

NCT number
NCT02867332
Sponsor
Peking University
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Renal Cell Carcinoma
Start date
2016-11-01
Primary completion
2020-11-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.